Comparative molecular docking of antitrypanosomal natural products into multiple trypanosoma brucei drug targets

Molecules

Volumn 14, Issue 4, 2009, Pages 1513-1536

  Ogungbe, Ifedayo V ^a   Setzer, William N ^a  

^a UNIVERSITY OF ALABAMA IN HUNTSVILLE   (United States)

Author keywords

Antitrypanosomal agents; Docking; Natural products; Protease; Sleeping sickness; Trypanosoma brucei

Indexed keywords

ANTITRYPANOSOMAL AGENT; BIOLOGICAL PRODUCT; CYSTEINE PROTEINASE; FLAVINE ADENINE NUCLEOTIDE; GERANYLTRANSFERASE; OXIDOREDUCTASE; RHODESAIN; TRIOSEPHOSPHATE ISOMERASE; TRYPANOTHIONE REDUCTASE;

AFRICAN TRYPANOSOMIASIS; ANIMAL; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG DEVELOPMENT; DRUG EFFECT; HUMAN; HYDROGEN BOND; METABOLISM; TRYPANOSOMA BRUCEI;

ANIMALS; BINDING SITES; BIOLOGICAL PRODUCTS; COMPUTER SIMULATION; CYSTEINE ENDOPEPTIDASES; DRUG DISCOVERY; FLAVIN-ADENINE DINUCLEOTIDE; GERANYLTRANSTRANSFERASE; HUMANS; HYDROGEN BONDING; MOLECULAR STRUCTURE; NADH, NADPH OXIDOREDUCTASES; TRIOSE-PHOSPHATE ISOMERASE; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 66349121399     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14041513     Document Type: Article

References (49)

1. Barrett, M.P.; Boykin, D.W.; Brun, R.; Tidwell, R.R. Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br. J. Pharmacol. 2007, 152, 1155-1171. 2
2. Koehn, F.E.; Carter, G. T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 2005, 4, 206-220.
3. Rollinger, J.M.; Stuppner, H.; Langer T. Virtual screening for the discovery of bioactive natural products. Prog. Drug Res. 2008, 65, 213-249.
4. Omar, M.; Khan, F. Trypanothione Reductase: A viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design. Drug Target Insights 2007, 1, 129-146.
5. Voet, D.; Voet, J.G. Biochemistry, 3rd Ed.; Wiley and Sons: New York, 2005; pp. 945-947.
6. Montalvetti, A.; Fernandez, A.; Sanders, J.M.; Ghosh, S.; Van Brussel, E.; Oldfield, E.; Docampo, R. Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei, in vitro RNA interference and in vivo inhibition studies. J. Biol. Chem. 2003, 278, 17075-17083.
7. Linares, G.E.G.; Ravaschino, E.L.; Rodriguez, J.B. Progresses in the field of drug design to combat tropical protozoan parasitic diseases. Curr. Med. Chem. 2006, 13, 335-360.
8. Mao, J.; Mukherjee, S.; Zhang, Y.; Cao, R.; Sanders, J.M.; Song, Y.; Zhang, Y.; Meints, G.A.; Gao, Y.G.; Mukkamala, D.; Hudock, M.P.; Oldfield, E. Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyl diphosphate synthase-bisphosphonate complexes. J. Am. Chem. Soc. 2006, 128, 14485-14497.
9. Docampo, R.; Moreno, S.N.J. Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites. Curr. Drug Targets Infect. Disord. 2001, 11, 51-61.
10. Tasdemir, D.; Güner, N.D.; Perozzo, R.; Brun, R.; Dönmez, A.A. ÇalIs, I.C.; Rüedi, P. Antiprotozoal and plasmodial FabI enzyme inhibiting metabolites of Scrophularia lepidota roots. Phytochemistry 2005, 66, 355-362.
11. Bringmann, G.; Hamm, A.; Gunter, C.; Michel, M.; Brun, R.; Mudogo, V. Ancistroealaines A and B, two new bioactive naphthylisoquinolines and related naphthoic acids from Ancistrocladus ealaensis. J. Nat. Prod. 2000, 63, 1465-1470.
12. Bringmann, G.; Wohlfarth, M.; Rischer, H.; Schlauer, J.; Brun, R. Extract screening by HPLC coupled to MS-MS, NMR, and CD: A dimeric and three monomeric naphthylisoquinoline alkaloids from Ancistrocladus griffithii. Phytochemistry 2002, 61, 195-204.
13. Bringmann, G.; Saeb, W.; Rückert M.; Mies J.; Michel M.; Brun R. Ancistrolikokine D, a 5,8′-coupled naphthylisoquinoline alkaloid, and related natural products from Ancistrocladus likoko. Phytochemistry 2003, 62, 631-636
14. Bringmann, G.; Dreyer, M.; Faber, J.H.; Dalsgaard, P.W., Staerk, D.; Jaroszewski J.W.; Ndangalasi, H.; Mbago, F.; Brun, R.; Reichert, M.; Maksimenka, K.; Christensen, S. B. Ancistrotanzanine A, the first 5,3′-coupled naphthylisoquinoline alkaloid, and two further, 5,8′-linked related compounds from the newly described plant species Ancistrocladus tanzaniensis. J. Nat. Prod. 2003, 66, 1159-1165.
15. Bringmann, G.; Dreyer, M.; Faber, J.H.; Dalsgaard, P.W.; Staerk, D.; Jaroszewski, J.W.; Ndangalasi, H.; Mbago, F.; Brun, R.; Maksimenka, K.; Christensen, S.B. Ancistrotanzanine C and related 5,1′-and 7,3′-coupled naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis. J. Nat. Prod. 2004, 67, 743-748.
16. Camacho, M.D.R.; Philipson, J.D.; Croft, S.L.; Rock, P.; Marshall, S.J.; Schiff, P.L. In vitroactivity of Triclisia patens and some bisbenzylisoquinone alkaloids against Leishmania dovovaniand Trypanosoma brucei brucei. Phytother. Res. 2002, 16, 432-436.
17. Merschjohann, K.; Sporer, F.; Steverding, D.; Wink M. In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense. Planta Med. 2001, 67, 623-627.
18. Bringmann, G.; Messer, K.; Wolf, K.; Mühlbacher J.; Grüne M. Dioncophylline E from Dioncophyllum tholonnii, the first 7,3′-coupled dioncophyllaceous naphthylisoquinoline alkaloid. Phytochemistry 2002, 60, 389-397.
19. Bringmann, G.; Messer, K.; Brun, R.; Mudogo, V. Ancistrocongolines A-D, new naphthylisoquinoline alkaloids from Ancistrocladus congolensis. J. Nat. Prod. 2002, 65, 1096-1101.
20. Labraña, J.; Machocho, A.K..; Kricsfalusy, V.; Brun, R.; Codina, C.; Viladomat, F.; Bastida, J. Alkaloids from Narcissus angustifolius subsp. transcarpathicus. Phytochemistry 2002, 60, 847-852.
21. Machocho, A.K..; Bastida, J.; Codina, C.; Viladomat, F.; Brun, R.; Chhabra S.C. Augustamine type alkaloids from Crinum kirkii. Phytochemistry 2004, 65, 847-852.
22. Senn, M.; Gunzenhauser, S.; Brun, R.; Séquin, U. Antiprotozoal polyacetylenes from the Tanzanian medicinal plant Cussonia zimmermannii. J. Nat. Prod. 2007, 70, 1565-1569.
23. Heilmann, J.; Brun, R.; Mayr, S.; Rali, T.; Sticher, O. Minor cytotoxic and antibacterial compounds from the rhizomes of Amomum aculeatum. Phytochemistry 2001, 57, 1281-1285.
24. Kamnaings, P.; Tsopmo, A.; Tanifum, E.A.; Tcheundem, M.H.K.; Tane, P.; Ayafor, J.F.; Sterner, O.; Rattendi, D.; Iwu, M.M.; Schuster, B.; Bacchi, C. Trypanocidal diarylheptanoids from Aframomum letestuianum. J. Nat. Prod. 2003, 66, 364-367.
25. Wright, A.D.; Papendorf, O.; König, G.M. Ambigol C and 2,4-Dichlorobenzoic Acid, new natural products produced by the terrestrial cyanobacterium Fischerella ambigua. J. Nat. Prod. 2005, 68, 459-461.
26. Pontius, A.; Krick, A.; Kehraus, S.; Brun, R.; König, G.M. Antiprotozoal activities of heterocyclic-substituted xanthones from the marine-derived fungus Chaetomium sp. J. Nat. Prod. 2008, 71, 1579-1584.
27. Ramírez, I.; Carabot, A.; Meléndez, P.; Carmona, J.; Jimenez, M.; Patel, A.V.; Crabb, T.A.; Blunden, G.; Cary, P.D.; Croft, S.L.; Costa, M. Cissampeloflavone, a chalcone-flavone dimer from Cissampelos pareira. Phytochemistry 2003, 64, 645-647.
28. Gertsch, J.; Tobler, R.T.; Brun, R.; Sticher, O.; Heilmann, J. Antifungal, antiprotozoal, cytotoxic and piscicidal properties of Justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum. Planta Med. 2003, 69, 420-424.
29. Asres, K.; Bucar, F.; Knauder, E.; Yardley, V.; Kendrick, H.; Croft S.L. In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle. Phytother. Res. 2001, 15, 613-617.
30. Mbwanbo, Z.H.; Apers, S.; Moshi, M.J.; Kapingu, M.C.; Van Miert, S.; Claeys, M.; Brun, R.; Cos, P.; Pieters, L.; Vlietinck, A. Anthranoid compounds with antiprotozoal activity from Vismia orientalis. Planta Med. 2004, 70, 706-710.
31. Jonckers, T.H.M.; van Miert, S.; Cimanga, K.; Bailly, C.; Colson, P.; De Pauw-Gillet, M.C.; van den Heuvel, H.; Claeys, M.; Lemiere, F.; Esmans, E.L.; Rozenski, J.; Quirijnen, L. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives. J. Med. Chem. 2002, 45, 3497-3508.
32. Moideen, S.V.K.; Houghton, P.J.; Rock, P.; Croft, S.L.; Aboagye-Nyame, F. Activity of extracts and naphthoquinones from Kigelia pinnata against Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. Planta Med. 1999, 65, 536-540.
33. Abegaz, B.M.; Bezabih, M.; Msuta, T.; Brun, R.; Menche, D.; Mühlbacher, J.; Bringmann, G. Gaboroquinones A and B and 4′-O-demethylknipholone-4′-O-β-D- glucopyranoside, phenylanthraquinones from the roots of Bulbine frutescens. J. Nat. Prod. 2002, 65, 1117-1121.
34. Schmidt, T.J.; Brun, R.; Willuhn, G.; Khalid, S.A. Anti-trypanosomal activity of helenalin and some structurally related sesquiterpene lactones. Planta Med. 2002, 68, 750-751.
35. Tchinda, A.T.; Tsopmo, A.; Tane, P.; Ayafor, J.F.; Conolly, J.D.; Sterner, O. Vernoguinosterol and vernoguinoside, trypanocidal stigmastane derivatives from Vernonia guineensis (Asteraceae). Phytochemistry 2002, 59, 371-374.
36. Cao, R.; Chen, C.K.M.; Guo, R.T.; Wang, A.H.J.; Oldfield, E. Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthases. Proteins 2008, 73, 431-439.
37. Vermelho, A.B.; De Simone, S.G.; d'Avila-Levy, C.M.; Souza do Santos, A.L.; Nogueira de Melo, A.C. Trypanosomatidae Peptidases: A target for drugs development. Curr. Enzyme Inhibit. 2007, 3, 19-48.
38. Sajid, M.; Mckerrow, J.H. Cysteine proteases of parasitic organisms. Mol. Biochem. Parasitol. 2002, 120, 1-21.
39. González, F.V.; Izquierdo, J.; Rodríguez, S.; McKerrow, J.H.; Hansell, E. Dipeptidyl-α,β-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain. Bioorg. Med. Chem. Lett. 2007, 17, 6697-6700.
40. Brinen, L.S.; Hansell, E.; Cheng, J.; Roush, W.R.; McKerrow, J.H.; Fletterick, R.J. A target within the target: probing cruzain's P1′ site to define structural determinants for the Chagas' disease protease. Structure 2000, 8, 831-840.
41. Krieger, S.; Schwarz, W.; Ariyanayagam, M.R.; Fairlamb, A.H.; Krauth-Siegel, R.L.; Clayton, C. Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Mol. Microbiol. 2000, 35, 542-552.
42. Jones, D.; Ariza, A.; Chow, W.H.A.; Oza, S.L.; Fairlamb, A.H. Properties of trypanothione reductase from T. brucei. Retrieved on 12/14/2008 from http://www.ncbi.nlm.nih.gov/Structure/mmdb/mmdbsrv.cgi?Dopt=s&uid=68081.
43. Michels, P.A.M. Compartmentation of glycolysis in trypanosomes: a potential target for new trypanocidal drugs. Biol. Cell 1988, 64, 157-164.
44. Bakker, B.M.; Michelsi, P.A.M.; Opperdoesi, F.R.; Hans, V.; Westerhoff, H.V. Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. J. Biol. Chem. 1999, 274, 14551-14559.
45. Olivares-Illana, V.; Pérez-Montfort, R.; López-Calahorra, F.; Costas, M.; Rodríguez-Romero, A.; Tuena de Gómez-Puyou, M.T.; Gómez Puyou, A. Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor. Biochemistry 2006, 45, 2556-2560.
46. Nickbarg, E.B.; Davenport, R.C.; Petsko, G.A.; Knowles J.R. Triosephosphate isomerase: removal of a putatively electrophilic histidine residue results in a subtle change in catalytic mechanism. Biochemistry 1988, 27, 5948-5960.
47. Dictionary of Natural Products on DVD. CRC Press, Taylor and Francis LLC: Boca Raton, Florida, USA, 1992-2008.
48. ACD/Chem. Sketch Freeware. Advanced Chemistry Development, Inc.: Toronto, Ontario, Canada, 1994-2006.
49. Thomsen, R.; Christensen, M.H. MolDock: a new technique for high-accuracy molecular docking. J. Med. Chem. 2006, 49, 3315-3321.